biote Corp. (BTMD) vs Microbot Medical Inc. (MBOT)
A side-by-side comparison of biote Corp. and Microbot Medical Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BTMD
biote Corp.
$1.19HealthcareDelayed quote: Oct 6, 2026, 10:51 AM EDT
MBOT
Microbot Medical Inc.
$1.08HealthcareDelayed quote: Oct 6, 2026, 10:55 AM EDT
Total return — BTMD vs MBOT
growth of $100 · dividends reinvested · last 5yBTMD -88.9% (-35.5%/yr)MBOT -86.2% (-32.7%/yr)MBOT compounded faster over this window
BTMD MBOT
BTMD vs MBOT: by the numbers
- •BTMD is the larger company ($52M vs $49M market cap).
- •BTMD is profitable (3.19% net margin) while MBOT runs a net loss (-4722.25%).
Metrics side by side
Valuation
| Metric | BTMD | MBOT |
|---|---|---|
| P/E ratio | 10.20 | N/A |
| P/S ratio | 0.29 | 141.58 |
| P/B ratio | N/A | 0.71 |
| EV / EBITDA | 9.14 | N/A |
| FCF yield | 37.50% | N/A |
Profitability
| Metric | BTMD | MBOT |
|---|---|---|
| Gross margin | 71.46% | 0.00% |
| Operating margin | 18.50% | 0.00% |
| Net margin | 3.19% | -4722.25% |
| ROE | N/A | -23.70% |
| ROIC | 13.63% | -26.51% |
Growth (annualized)
| Metric | BTMD | MBOT |
|---|---|---|
| Revenue CAGR (5Y) | 10.52% | N/A |
| EPS CAGR (5Y) | -25.90% | N/A |
| FCF CAGR (5Y) | 3.81% | N/A |
| Total return CAGR (5Y) | -35.12% | -31.63% |
Frequently asked
- Is BTMD or MBOT more profitable?
- BTMD runs the higher net margin — BTMD at 3.19% versus MBOT at -4722.25%.
- How have BTMD and MBOT total returns compared?
- Over the past 5 years, BTMD delivered -35.12% and MBOT delivered -31.63% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
biote P/E ratiobiote ROEMicrobot Medical ROEbiote operating marginMicrobot Medical operating marginbiote revenue growthMicrobot Medical revenue growthbiote free cash flowMicrobot Medical free cash flow
biote & Microbot Medical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.